CD8A and neoplasm: Consistent with the enhanced tumor infiltration by CD8+ T cells, aldometanib did not affect the maturation of CD8+ T cells in the thymus, as the mature thymic CD8+ single-positive T cells that can differentiate into various types of CD8+ T cells were not changed (Supplementary information, Fig. S8o).